Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 17, 2025European Journal Of HaematologyOpen Access

Review outlines multidisciplinary diagnosis and tailored therapies for managing persistent hypereosinophilic syndromes.

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Clinical manifestations of eosinophilia-related disorders range from mild to life-threatening, requiring a comprehensive multidisciplinary diagnostic and therapeutic approach.

Design

Review

Key result

This review outlines the clinical management of persistent hypereosinophilia, emphasizing a multidisciplinary diagnostic approach and therapies tailored to specific hypereosinophilic syndrome subtypes.

Authors

GHGrzegorz HelbigKCKacper Czachor

Discussion

Loading...

Member takes

Overview

Supports multidisciplinary diagnostics in persistent hypereosinophilia; leaves open prospective validation of subtype-specific therapies.

Structured PICO

P
Population
Patients with persistent peripheral blood hypereosinophilia (HE ≥ 1500/mm3) and end-organ damage (hypereosinophilic syndromes)
E
Exposure
Diagnostic evaluation and therapies including corticosteroids, anti-interleukin-5 monoclonal antibodies, and targeted oral molecules

This review provides a comprehensive hematologic perspective on the diagnostic algorithm and therapeutic management of persistent hypereosinophilia and hypereosinophilic syndromes.

Cite This Study

Helbig et al. (2025) conducted a review in Persistent Hypereosinophilia. Clinical management was evaluated. This review outlines the clinical management of persistent hypereosinophilia, emphasizing a multidisciplinary diagnostic approach and therapies tailored to specific hypereosinophilic syndrome subtypes.

synapsesocial.com/papers/6aa941ead0c7c778ac8cc550https://doi.org/10.1111/ejh.14396
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clinical and Therapeutic Intervention of Hypereosinophilia in the Era of Molecular Diagnosis2024 · 12 citations
  2. 2World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management2024 · 39 citations
  3. 3Severe Persistent Hypereosinophilia of Undetermined Significance: Diagnostic Challenges in Clinical Practice and Two-Year Follow-Up2026
  4. 4Eosinophilia and Hypereosinophilia: A Practical Approach to Navigating a Broad Differential Diagnosis2026
  5. 5Factors predicting the final diagnosis of peripheral blood hypereosinophilia-- a retrospective analysis2024